Adaptive Biotechnologies ...

NASDAQ: ADPT · Real-Time Price · USD
13.03
0.11 (0.85%)
At close: Aug 15, 2025, 3:59 PM
13.05
0.15%
After-hours: Aug 15, 2025, 07:25 PM EDT

Adaptive Biotechnologies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-25.59M -29.83M -33.72M -32.12M -46.22M -47.53M -69.44M -50.33M -47.81M -57.7M -40.17M -45.32M -52.08M -62.8M -61.36M -56M -49.3M -40.64M
Depreciation & Amortization
4.5M 4.73M 4.45M 4.59M 5M 5.21M 5.39M 5.76M 5.65M 5.42M 5.29M 5.38M 5.2M 5.06M 4.85M 3.53M 2.9M 2.67M
Stock-Based Compensation
13.36M 12.15M 12.83M 13.52M 12.96M 14.3M 15.56M 15.34M 17.34M 14.67M 14.29M 14.14M 14.18M 12.86M 11.88M 11.64M 11.25M 8.48M
Other Working Capital
n/a -14.54M 570K 11.59M -3.17M -4.94M -6.06M -11.57M -7.65M -26.95M -7.11M -22.1M -16.33M -7.82M -14.79M -12.76M -19.51M -12.27M
Other Non-Cash Items
-4.7M -15.53M 893K -20.54M 25.1M 2.37M 48.86M 3.71M 3.05M 2.93M 1.05M 2.48M 5.13M 2.63M 1.7M 1.77M 1.76M 1.72M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -23.79M -2.52M -2.24M n/a n/a n/a n/a n/a 1.28M 1.78M 2.07M 2.11M
Change in Working Capital
n/a n/a 3.05M 7.48M 2.83M -10.31M -3.51M -18.64M 449K -24.48M -10.48M -19.37M -19.48M -22.21M -12.17M -6.17M -5.89M -32.59M
Operating Cash Flow
-12.43M -28.48M -12.49M -27.07M -17.3M -38.35M -26.93M -46.68M -23.56M -59.15M -30.02M -42.41M -47.06M -64.45M -53.83M -43.44M -37.21M -58.24M
Capital Expenditures
-655K -1.26M -80K -344K -1.73M -1.51M -1.3M -2.78M -3.7M -2.92M -2.54M -5.43M -5.3M -3.08M -9.24M -14.62M -22.04M -15.84M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -4.5M -28.92M -41.02M n/a 95M n/a -10.04M n/a n/a n/a n/a n/a
Purchase of Investments
-51.14M -50.65M -44.8M -63.26M -82.72M -53.48M -122M -119.08M -99.38M -89.1M -165.03M -28.55M -24.96M -60.23M -78.54M -141.65M -81.01M -15.34M
Sales Maturities Of Investments
55.14M 77.49M 67M 68.89M 90.33M 99.5M 126.5M 148M 140.4M 155M 70.03M 92M 35M 101M 155M 135M 144.5M 125M
Other Investing Acitivies
n/a n/a n/a n/a 7.61M 46.02M 4.5M 28.92M 41.02M n/a -95M 63.45M 10.04M 40.77M 76.46M -6.65M 63.49M 109.66M
Investing Cash Flow
3.35M 25.57M 22.12M 5.29M 5.88M 44.51M 3.21M 26.14M 37.32M 62.98M -97.54M 58.02M 4.75M 37.69M 67.21M -21.27M 41.45M 93.82M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.61M 5.45M 127K 40K 30K 44K 87K 17K 1.47M 672K 6K 125.52M 3.99M 2.75M 3.28M 2.93M 6.33M 14.19M
Financial Cash Flow
1.61M 5.45M 127K 40K 30K 44K 87K 17K 1.47M 672K 6K 125.52M 3.99M 2.75M 3.28M 2.93M 6.33M 14.61M
Net Cash Flow
-7.47M 2.54M 9.76M -18.76M -11.41M 6.2M -23.65M -20.53M 15.24M 4.5M -127.56M 141.13M -38.33M -24.02M 16.66M -61.78M 10.56M 50.19M
Free Cash Flow
-13.09M -29.74M -12.57M -27.41M -19.03M -39.86M -28.23M -49.46M -27.25M -62.08M -32.56M -47.84M -52.36M -67.53M -63.07M -58.06M -59.25M -74.09M